Markets:

Overview

News

Currencies

International

Treasuries

Apellis Pharmaceuticals, Inc. - Common Stock (NQ:APLS)

19.73 -0.37 (-1.84%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 18, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Apellis Pharmaceuticals, Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

19 20 Next >

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 11, 2023

Via Benzinga

Consolidated Water, Spectrum Brands, Arco Platform, Semler Scientific And Other Big Stocks Moving Higher On Friday ↗

August 11, 2023

U.S. stocks traded mixed, with the Dow Jones gaining around 80 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Apellis Pharmaceuticals, Inc. (APLS) on Behalf of Investors

August 11, 2023

From Glancy Prongay & Murray LLP

Via Business Wire

Where Apellis Pharmaceuticals Stands With Analysts ↗

August 03, 2023

Via Benzinga

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Apellis Pharmaceuticals, Inc. (APLS) on Behalf of Investors

August 10, 2023

From Law Offices of Howard G. Smith

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of Apellis Pharmaceuticals, Inc. (APLS) on Behalf of Investors

August 10, 2023

From The Law Offices of Frank R. Cruz

Via Business Wire

Apellis Pharmaceuticals, Inc. (APLS) Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Apellis Pharmaceuticals, Inc. Class Action

August 09, 2023

From Robbins LLP

Via Business Wire

APELLIS PHARMACEUTICALS, INC. (NASDAQ: APLS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Apellis Pharmaceuticals, Inc.

August 08, 2023

From Bernstein Liebhard LLP

Via GlobeNewswire

APELLIS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Apellis Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

August 08, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

ROSEN, A TOP RANKED LAW FIRM, Encourages Apellis Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – APLS

August 07, 2023

From The Rosen Law Firm, P.A.

Via Business Wire

Why Krystal Biotech Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

August 07, 2023

Gainers Vistagen Therapeutics, Inc. (NASDAQ: VTGN) shares jumped 747.6% to $14.24 after the company announced its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of...

Via Benzinga

Here's Why Embattled Apellis Stock, A Former Highflier, Just Took Another Hit To The Chin ↗

August 07, 2023

The company is already under scrutiny after reports of side effects tied to Syfovre.

Via Investor's Business Daily

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 07, 2023

Via Benzinga

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Apellis Pharmaceuticals, Inc. with Losses of $750,000 to Contact the Firm

August 06, 2023

Via ACCESSWIRE

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Apellis Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation - APLS

August 06, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 04, 2023

From Apellis Pharmaceuticals, Inc.

Via GlobeNewswire

APELLIS PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Apellis Pharmaceuticals, Inc. (NASDAQ: APLS)

August 04, 2023

From Bernstein Liebhard LLP

Via GlobeNewswire

APELLIS PHARMACEUTICALS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Apellis Pharmaceuticals, Inc. - APLS

August 03, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Shareholder Alert: Robbins LLP Informs Shareholders of Class Action Filed Against Apellis Pharmaceuticals, Inc. (APLS)

August 03, 2023

From Robbins LLP

Via Business Wire

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Apellis Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation - APLS

August 03, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2023 ↗

August 03, 2023

Via Benzinga

APLS Investor Alert: Kessler Topaz Meltzer & Check, LLP and Bernstein Litowitz Berger & Grossmann LLP Announce the Filing of a Securities Class Action Lawsuit Against Apellis Pharmaceuticals, Inc.

August 02, 2023

From Kessler Topaz Meltzer & Check, LLP

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

August 01, 2023

On Tuesday, 46 stocks hit new 52-week lows.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2023 ↗

August 01, 2023

Via Benzinga

Why Apellis Pharmaceuticals Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Monday's Session ↗

July 31, 2023

Gainers Yellow Corporation (NASDAQ: YELL) shares jumped 106% to $1.46. The trucking company ceased operations on Sunday, according to a Wall Street Journal report.

Via Benzinga

Apellis Crashes As Safety Issues Outweigh Massive Eye-Drug Sales Beat ↗

July 31, 2023

Apellis crashed after Syfovre safety issues continued to plague the stock.

Via Investor's Business Daily

Stocks That Hit 52-Week Lows On Monday ↗

July 31, 2023

On Monday, 27 stocks hit new 52-week lows.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

July 31, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 31, 2023

Via Benzinga

Rising Stars, Falling Trends: July's Industry ETF Winners And Losers ↗

July 31, 2023

Via Benzinga

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Apellis Pharmaceuticals, Inc. - Common Stock (NQ:APLS)

All News about Apellis Pharmaceuticals, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today